Advertisement

Topics

Cancer Reports

22:16 EDT 19th September 2017 | BioPortfolio

Rexahn Pharmaceuticals Inc RNN Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 22082017] Prices from USD $250

SummaryRexahn Pharmaceuticals Inc Rexahn Pharmaceuticals, formerly Corporate Road Show.com Inc is a clinical stage biopharmaceutical company that offers discovery, development and commercialization of therapeutics for the treatment of cancer. The company develops anticancer drug candidates which include Archexin that is intended for the treatment of pancreatic cancer. It develops RX3117 used for t...

Oregon Health Science University Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 23082017] Prices from USD $250

SummaryOregon Health Science University OHSU, a subsidiary of Oregon State University is an academic health center that provides medical education, research, patient care and community services. The center's educational institute offers undergraduate and graduate courses in anesthesiology, dermatology, neurology, psychiatry, periodontology and nursing. It grants doctoral degrees in medicine, dent...

H. Lee Moffitt Cancer Center Research Institute Inc Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 24082017] Prices from USD $250

SummaryH Lee Moffitt Cancer Center Research Institute Inc Moffitt is a healthcare service provider that concentrates on the development of early stage translational research aimed at the rapid translation of scientific discoveries to benefit patient care. The center offers medical services such as surgical care, fertility preservation, radiation therapy, interventional radiology, rehabilitation s...

Pain Therapeutics Drugs, Markets and Companies [Report Updated: 08092017] Prices from USD $4000

SummaryThis report describes the latest concepts of pathomechanisms of pain as a basis for management and development of new pharmacotherapies for pain. Major segments of the pain market are arthritis, neuropathic pain and cancer pain. Because pain is a subjective sensation, it is difficult to evaluate objectively in clinical trials. Various tools for pain measurement are described, including brai...

RAC Gamma Serine/Threonine Protein Kinase Protein Kinase Akt 3 or Protein Kinase B Gamma or RAC PK Gamma or STK 2 or AKT3 or EC 2.7.11.1 Pipeline Review, H2 2017 [Report Updated: 29082017] Prices from USD $3500

RAC Gamma Serine/Threonine Protein Kinase Protein Kinase Akt 3 or Protein Kinase B Gamma or RAC PK Gamma or STK 2 or AKT3 or EC 2.7.11.1 Pipeline Review, H2 2017SummaryRAC Gamma Serine/Threonine Protein Kinase Protein Kinase Akt 3 or Protein Kinase B Gamma or RAC PK Gamma or STK 2 or AKT3 or EC 2.7.11.1 RACgamma serine/threonineprotein kinase is an enzyme encoded by the AKT3 gene. AKT3 regulate ...

Minerva Biotechnologies Corp Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 22082017] Prices from USD $250

SummaryMinerva Biotechnologies Corp Minerva is a biotechnology company that develops immunotherapies and cancer drugs. The company offers antibody for Tcell immunotherapy, which is used in advanced breast and ovarian cancers; and humanized antibodies used for prostate and breast cancer. It offers antimetastasis antibody that block the metastatic growth factor and transition from a regular cancer c...

Cyclin Dependent Like Kinase 5 Serine/Threonine Protein Kinase PSSALRE or Tau Protein Kinase II Catalytic Subunit or Cell Division Protein Kinase 5 or CDK5 or EC 2.7.11.1 Pipeline Review, H2 2017 [Report Updated: 29082017] Prices from USD $3500

Cyclin Dependent Like Kinase 5 Serine/Threonine Protein Kinase PSSALRE or Tau Protein Kinase II Catalytic Subunit or Cell Division Protein Kinase 5 or CDK5 or EC 2.7.11.1 Pipeline Review, H2 2017SummaryAccording to the recently published report 'Cyclin Dependent Like Kinase 5 Pipeline Review, H2 2017'; Cyclin Dependent Like Kinase 5 Serine/Threonine Protein Kinase PSSALRE or Tau Protein Kinase I...

AIMM Therapeutics BV Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 24082017] Prices from USD $250

SummaryAIMM Therapeutics BV AIMM Therapeutics is a biotechnology company that develops progressive approach to the discovery of therapeutic antibodies for the treatment of cancer and infectious diseases. The company offers research programs for prevention and treatment of diseases with medical needs which include cancer, infectious, inflammatory and autoimmune diseases. It sources antibodies from ...

Formation Biologics Inc Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 28082017] Prices from USD $250

SummaryFormation Biologics Inc Formation Biologics, formerly AvidBiologics Inc. is a biotechnology company that develops biologics and antibodydrug conjugates ADCs with selective antitumor properties for the treatment of cancer. The company's pipeline includes AVID100 antibodydrug conjugate for solid Tumours, and AVID200 TGF beta neutralizing immunotherapy. Its ADCs prevents the inadvertent destr...

Nanobiotix SA NANO Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 22082017] Prices from USD $250

SummaryNanobiotix SA Nanobiotix is a nanomedicine company that develops tools for local treatment of cancer. The company provides products such as NBTXR3, NBTX IV and TOPO NBTX. Its NBTXR3 nanoparticles are designed for direct injection into the tumor. Nanobiotix's NBTXIV nanoparticles are designed for intravenous injection. The company's NBTXTOPO nanoparticles is a gel to be applied during surger...

ZIOPHARM Oncology Inc ZIOP Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 23082017] Prices from USD $250

SummaryZiopharm Oncology Inc Ziopharm, formerly EasyWeb Inc is a biotechnology company that discovers and develops cancer therapies. The company develops novel gene expression, control and cell technologies to provides cellbased therapies for the treatment of cancer and graftversushostdisease GvHD. It offers engineering techniques and multigenic gene programs to develop nextgeneration patient and ...

PharmaEngine Inc 4162 Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 22082017] Prices from USD $250

SummaryPharmaEngine Inc PharmaEngine is a biopharmaceutical company that develops cancer treatment drugs. The company develops drugs for the treatment of cancer and Asian prevalent diseases. Its products comprise Onivyde, a liposome encapsulation of irinotecan. PharmaEngine also develops PEP503, NBTXR3 and PEP06 in lead optimization. The company's products are used for the treatment of various typ...

Sanford Burnham Prebys Medical Discovery Institute Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 23082017] Prices from USD $250

SummarySanford Burnham Prebys Medical Discovery Institute Sanford Burnham is a nonprofit public benefit institute that offers medical research services. The institute offers research programs in the field of tumor initiation and maintenance, cancer metabolism and signaling networks, tumor microenvironment and cancer immunology, degenerative diseases, immunity and pathogenesis, human genetics devel...

Xintela AB Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 22082017] Prices from USD $250

SummaryXintela AB Xintela is a biomedical company that develops treatment for cartilage damage and brain tumors such as Glioblastoma. The company's technology includes Xinmark, a patented marker technology developed to identify and select certain types of tumor cells, which can develop into cartilage cells. It also provides analytical test such as XACT Xintela Assay for Cell Therapy, used for qual...

Oncogenex Pharmaceuticals Inc OGXI Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 22082017] Prices from USD $250

SummaryOncogenex Pharmaceuticals Inc OncoGenex is a drug discovery and development company that develops and commercializes therapies and mechaisms for addressing treatment resistance in cancer patients. The company's products include custirsen and apatorsen. Its custirsen drug is designed to block the production of clusterin, a cytoprotective protein which is upregulated in tumor cells in respons...

Global Colorectal Cancer Partnering 2010 to 2017 [Report Updated: 01092017] Prices from USD $1495

The Global Colorectal Cancer Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies. Trends in partnering deals Top deals by value Deals listed by company AZ, industry sector, stage of development, technology typeThe report provides understanding and access to the partnering dea...

2017 Spain Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing: Supplier Shares by Country and Segment Forecasts, Emerging Technologies, Competitive Strategies [Report Updated: 23082017] Prices from USD $1850

Complete report $1,850. nbsp;DataPack test volumes, sales forecasts, supplier shares $1,200.The report is available by section, market segment, and can be customtailored to your specific information needs and budget.This new study from VPGMarketResearchnbsp;contains 407 pages, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities for m...

Sunshine Biopharma Inc SBFM Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 22082017] Prices from USD $250

SummarySunshine BioPharma Inc Sunshine BioPharma, a subsidiary of Advanomics Corp is a pharmaceutical company that provides research, development and commercialization of drugs for treating cancer disease. The company offers generic and proprietary drugs for the treatment of cancer and other acute and chronic indications. It's drug candidate include Adva27a, a small molecule against different type...

Kadmon Holdings Inc KDMN Financial and Strategic SWOT Analysis Review [Report Updated: 06092017] Prices from USD $125

Kadmon Holdings Inc KDMN Financial and Strategic SWOT Analysis Review provides you an indepth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment y...

Global Gastric Cancer Partnering 2010 to 2017 [Report Updated: 01092017] Prices from USD $1495

The Global Gastric Cancer Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies. Trends in partnering deals Top deals by value Deals listed by company AZ, industry sector, stage of development, technology typeThe report provides understanding and access to the partnering deals ...

Global Brain Cancer Partnering 2010 to 2017 [Report Updated: 01092017] Prices from USD $1495

The Global Brain Cancer Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies. Trends in partnering deals Top deals by value Deals listed by company AZ, industry sector, stage of development, technology typeThe report provides understanding and access to the partnering deals an...

Nuclear Receptor ROR Gamma Nuclear Receptor RZR Gamma or Nuclear Receptor Subfamily 1 Group F Member 3 or RAR Related Orphan Receptor C or Retinoid Related Orphan Receptor Gamma or RORC Pipeline Review, H2 2017 [Report Updated: 29082017] Prices from USD

Nuclear Receptor ROR Gamma Nuclear Receptor RZR Gamma or Nuclear Receptor Subfamily 1 Group F Member 3 or RAR Related Orphan Receptor C or Retinoid Related Orphan Receptor Gamma or RORC Pipeline Review, H2 2017SummaryNuclear Receptor ROR Gamma Nuclear Receptor RZR Gamma or Nuclear Receptor Subfamily 1 Group F Member 3 or RAR Related Orphan Receptor C or Retinoid Related Orphan Receptor Gamma or R...

ESSA Pharma Inc EPI Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 23082017] Prices from USD $250

SummaryEssa Pharma Inc Essa Pharma is a clinicalstage pharmaceutical company that carries out the development of small molecule drugs for the treatment castrationresistant prostate cancer CRPC. The company's lead product candidate, EPI506, disrupts androgen receptor AR transcriptional activity through selectively blocking the Nterminal domain of the AR. It also conducts research on prostate cancer...

Jounce Therapeutics Inc JNCE Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 28082017] Prices from USD $250

SummaryJounce Therapeutics Inc Jounce is a biotechnology company. The company concentrates on the discovery and development of cancer immunotherapies, which enable the patient's immune system to search for and attack cancerous cells and tumors. Its lead candidate ICOS is an agonist monoclonal antibody which stimulates T effector cells to enhance antitumor activity. It harnesses its proprietary pro...

European Institute of Oncology Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 28082017] Prices from USD $250

SummaryEuropean Institute of Oncology IEO is a research institute that conducts clinical and scientific research on cancer prevention, early diagnosis and treatment of cancer. The institute offers medical care services for breast tumors, lung tumors, cervical tumors, endometrial tumors, thoracic tumors, ovarian tumors, prostate tumors, urological tumors, stomach tumors, bowel tumors, and others. I...

Quick Search
Advertisement
 

review and buy Cancer market research data and corporate reports here